Advanced Gas-cooled Reactor
Advanced Gas-cooled Reactor | |
---|---|
Reactor concept | {{{concept}}} |
Reactor type | Gas-cooled reactor |
Main parameters of the reactor core | |
Fuel (fissile material) | Information missing |
Fuel state | {{{fuel_state}}} |
Neutron energy spectrum | Information missing |
Primary control method | {{{control}}} |
Primary moderator | Graphite |
Primary coolant | Carbon dioxide |
Reactor usage | |
Primary use | {{{use}}} |
An Advanced Gas-cooled Reactor (AGR) is a type of nuclear reactor that uses carbon dioxide as a coolant and graphite as a moderator. The AGR was developed in the United Kingdom as a successor to the Magnox reactor and is primarily used for generating electricity.
Design and Operation[edit | edit source]
The AGR design features a graphite moderator and a carbon dioxide coolant. The fuel used in AGRs is uranium dioxide pellets, which are enriched to a higher level than those used in Magnox reactors. The fuel is contained in stainless steel cladding, which allows for higher operating temperatures and improved thermal efficiency.
The reactor core is composed of a large graphite block with channels drilled through it to accommodate the fuel assemblies and coolant flow. The carbon dioxide coolant is circulated through the core, where it absorbs heat from the fuel. The heated gas then passes through a heat exchanger, where it transfers its heat to water, producing steam. This steam drives a turbine connected to a generator, producing electricity.
Safety Features[edit | edit source]
AGRs incorporate several safety features, including:
- A robust containment structure to prevent the release of radioactive materials.
- Multiple redundant cooling systems to ensure the reactor can be safely shut down in the event of an emergency.
- A negative temperature coefficient of reactivity, which means that the reactor's power output decreases as the temperature increases, providing inherent safety.
History[edit | edit source]
The first AGR, the Dungeness B reactor, began construction in the 1960s and became operational in the 1980s. Several other AGRs were subsequently built in the UK, including the Hinkley Point B, Hunterston B, and Torness reactors. These reactors have provided a significant portion of the UK's electricity supply for several decades.
Advantages and Disadvantages[edit | edit source]
Advantages[edit | edit source]
- Higher thermal efficiency compared to Magnox reactors.
- Use of enriched uranium allows for longer fuel cycles and higher burn-up rates.
- Robust safety features and containment structures.
Disadvantages[edit | edit source]
- Complex design and construction, leading to higher initial costs.
- Longer construction times compared to other reactor types.
- Limited to the UK, with no significant international deployment.
Related Pages[edit | edit source]
- Nuclear power
- Nuclear reactor
- Magnox reactor
- Graphite-moderated reactor
- Carbon dioxide
- Electricity generation
See Also[edit | edit source]
This nuclear power related article is a stub. You can help WikiMD by expanding it.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD